SupraQ-PW an innovative non-invasive ultrasound device for cardiac output and fluid status management for all hospitalised patients.
SupraQ-PW 是一种创新的非侵入性超声设备,用于对所有住院患者进行心输出量和体液状态管理。
基本信息
- 批准号:10022495
- 负责人:
- 金额:$ 44.03万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Collaborative R&D
- 财政年份:2022
- 资助国家:英国
- 起止时间:2022 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Deltex Medical has been awarded an Innovate UK Smart Award to complete the development of SupraQ-PW. SupraQ-PW is an innovative hand-held non-invasive device for the assessment of cardiac function and fluid status for all hospitalised patients. Clinicians currently lack a simple, reliable, non-invasive haemodynamic monitor that rapidly and accurately assesses the circulatory status of sick non-ventilated patients, and then guides their treatment. SupraQ-PW will be used in A&E, pre-surgical screening, critical care, obstetrics and cardiology. Prompt diagnosis for Covid-19 patients, is critical before their circulatory problem becomes severe. Use to guide treatment would improve patient outcomes, reduce hospital stay, improve utilization of stretched resources and deliver economic benefits. SupraQ-PW will Pulse Wave ultrasound which has the advantage that it can echolocate the point of measurement. The system is non-invasive and can be used on non-ventilated awake patients across all hospital settings. This development is the result of over 10years research into the optimal design for a non-invasive Doppler ultrasound cardiac output device. The probe is placed in the suprasternal notch (V-shaped notch at top of the sternum at the base of the neck). From this position ultrasound can be directed down the patient's aorta without skeletal bone obscuring the beam. This innovative device is easy to use and provides accurate and reproducible measurements of cardiac function and fluid status without patient harm. SupraQ-PW is compatible with Deltex's latest portable TrueVue monitors such that no additional monitoring device is required.Medicine today faces increasingly complex cases as the population ages. Protecting patients from haemodynamic errors through improved monitoring would save thousands of lives, improve outcomes and reduce costs. Haemodynamic instability and low blood pressure are frequent, with consequences such as myocardial infarctions, stroke and kidney injury. Complications have serious clinical and financial consequences; unplanned intensive care admissions; longer hospital stay; increased readmissions; increased 30-day mortality; and shorter patient lifespan after discharge. The ability to quickly and simply screen in-patients at admission and throughout their care will be a significant contribution to patient safety, in-hospital care and post discharge outcomes. This development is a significant moment for Deltex in its mission to provide non-invasive measurements of cardiac output for all hospitalised patients. SupraQ-PW addresses a market need in Deltex's immediately accessible market of 4 direct territories and 23 distributors and potentially 16 million devices per annum. Deltex expects cumulative sales of £32 million by the end of the 5th year after launch.
Deltex Medical已被授予Innovate UK Smart Award,以完成SupraQ-PW的开发。SupraQ-PW是一种创新的手持式无创器械,用于评估所有住院患者的心脏功能和液体状态。临床医生目前缺乏一种简单、可靠、无创的血液动力学监测仪,可以快速准确地评估非通气患者的循环状态,然后指导他们的治疗。SupraQ-PW将用于A&E、术前筛查、重症监护、产科和心脏病学。在新冠肺炎患者的循环系统问题变得严重之前,及时诊断至关重要。用于指导治疗将改善患者的治疗效果,减少住院时间,提高紧张资源的利用率,并带来经济效益。SupraQ-PW将脉冲波超声,其优点是可以回声定位测量点。该系统是非侵入性的,可用于所有医院环境中未通气的清醒患者。这一发展是对无创多普勒超声心输出量设备的最佳设计进行了10多年研究的结果。将探头放置在胸骨上切迹(颈部底部胸骨顶部的V形切迹)中。从这个位置,超声可以被引导到患者的主动脉,而不会有骨骼遮挡波束。这种创新的设备易于使用,并提供准确和可重复的心脏功能和液体状态的测量,而不会对患者造成伤害。SupraQ-PW与Deltex最新的便携式TrueVue监护仪兼容,因此无需额外的监护设备。随着人口老龄化,当今医学面临着越来越复杂的病例。通过改善监测,保护患者免受血液动力学错误的影响,将挽救数千人的生命,改善结果并降低成本。血液动力学不稳定和低血压是常见的,其后果如心肌梗死、中风和肾损伤。并发症具有严重的临床和经济后果;计划外重症监护入院;住院时间更长;再入院增加; 30天死亡率增加;出院后患者寿命缩短。在入院时和整个护理过程中快速简单地筛查住院患者的能力将对患者安全、住院护理和出院后结果做出重大贡献。这一发展是Deltex在其使命中的一个重要时刻,为所有住院患者提供无创心输出量测量。SupraQ-PW解决了Deltex直接进入的市场需求,该市场包括4个直接地区和23个分销商,每年可能有1600万台设备。Deltex预计,到推出后的第5年年底,累计销售额将达到3200万英镑。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
相似国自然基金
PSf-Al2O3-PW12O40三元复合膜的构建及其抗污染机理研究
- 批准号:
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于固态多孔杂多酸(K3PW12O40)可见光催化选择性氧化醇类化合物的研究
- 批准号:21103149
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation on the formation of high temperature non-LTE solid density high-Z plasma by PW-class femtsecond laser
PW级飞秒激光器高温非LTE固体密度高Z等离子体形成研究
- 批准号:
22H00121 - 财政年份:2022
- 资助金额:
$ 44.03万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of technologies for high-repetition rate PW level laser systems
高重复频率PW级激光系统技术的开发
- 批准号:
2473042 - 财政年份:2020
- 资助金额:
$ 44.03万 - 项目类别:
Studentship
SCI: IRNC: TransLight/Pacific Wave (TOPS-PW)
SCI:IRNC:跨光/太平洋波 (TOPS-PW)
- 批准号:
0441119 - 财政年份:2005
- 资助金额:
$ 44.03万 - 项目类别:
Cooperative Agreement